Menu

Blog Posts

News Alert

AbbVie Puts Squeeze on 340B Pricing for Hospitals Akin to J&J and Amgen’s Recent Moves

In News Alert, Pharma Industry1757 Views Tom Mirga
AbbVie facility gate
AbbVie this morning significantly tightened its restrictions on 340B pricing for hospitals, along the lines of Amgen and Johnson & Johnson's recent moves.

Drug manufacturer AbbVie this morning significantly tightened its restrictions on 340B pricing for hospitals.

AbbVie has not yet responded to a request for comment about the changes. Non-hospital covered entities continue to be exempt from AbbVie’s pricing restrictions.

…
Read More »

News Alert

U.S. House Panel Debates 340B in Context of Health Care Transparency and Consolidation

In Federal, Legislative, News Alert1463 Views Tom Mirga
Congresswoman Doris Matsui
“There’s been a lot of criticism of the 340B program lately and I’m concerned about the conversation on 340B happening today,” Rep. Doris Matsui (D-Calif.) said during a House Energy & Commerce health subcommittee hearing today.

The 340B program was discussed at length today during a U.S. House subcommittee hearing on price transparency and consolidation in health care, with three Republicans questioning whether hospitals are abusing the program and two Democrats and a Republican

…
Read More »

RWC-340B Opposes and Hemophilia Alliance Questions PhRMA and NACHC’s Push to Remake 340B

In Federal, Legislative, Pharma Industry, Providers883 Views Tom Mirga
RWC-340B Hemophilia Alliance wordmarks
RWC-340B rejected and Hemophilia Alliance criticized PhRMA and NACHC's joint plan to restructure the 340B program.

Ryan White Clinics for 340B Access has announced it opposes the drug industry’s joint plan with community health centers to restructure the 340B program, saying it will increase manufacturers’ “already astronomical profits at the expense of safety net

…
Read More »

340B Expected to Be Addressed During U.S. House Hearing Today

In Federal, Legislative693 Views Tom Mirga
E&C committee room
The 340B program is expected to come up today during a U.S. House Energy & Commerce health subcommittee hearing.

Lawmakers and heath care policy experts are expected to discuss the 340B program this afternoon during a U.S. House Energy & Commerce health subcommittee hearing.

The hearing on lowering health care costs through more price transparency and

…
Read More »

AHF: Addressing Syphilis Disparities in Franklin County, OH

In Sponsored Content, Uncategorized275 Views Sponsored Content
Aids Healthcare Foundation logo
Effective strategies for controlling syphilis transmissions and why it is so important

SPONSORED CONTENT

In 1999, the Centers for Disease Control and Prevention (CDC) launched the National Campaign to Eliminate Syphilis from the United States. The CDC updated its ambitious plan in 2006 and aimed to reduce rates of primary and secondary syphilis to less than 2.2 cases per 100,000 population, congenital syphilis

…
Read More »

N.Y. State Health Centers Sue to Stop April 1 Shift of Medicaid Managed Care Drug Benefits to Fee for Service

In Legislative, State275 Views Laura Gilcrest and Tom Mirga
Evergreen Health wordmark
Buffalo, N.Y.-based health center Evergreen Health and Harlem, N.Y.-based health health center Heritage Health and Housing asked a state court to halt Saturday's scheduled transfer of Medicaid drug benefits from managed care to fee for service.

The clock is ticking down in New York state to the scheduled April 1 transfer of Medicaid managed care drug benefits to Medicaid fee for service—a move that 340B safety net providers say would result in financial disaster.

…
Read More »

HRSA Posts Two Drug Manufacturer Notices to 340B Entities

In Federal, Regulatory232 Views Laura Gilcrest
Vtama pharmaceutical product tube
Dermavant Sciences is giving refunds to health care providers that paid above the 340B ceiling price for Vtama, a treatment for plaque psoriasis.

Biopharmaceutical company Dermavant Sciences is giving refunds to health care providers that paid above the 340B ceiling price for Vtama, a non-steroidal cream to treat plaque psoriasis.

The U.S. Health Resources and Services Administration posted Dermavant’s notice to

…
Read More »

Confidential Document Fleshes Out ASAP 340B’s Reform Objectives

In Federal, Pharma Industry, Providers1732 Views Tom Mirga
Excerpt from a confidential PhRMA principles document
PhRMA has written an eight-page document that elaborates on its principles for 340B program reform.

A confidential document composed by Pharmaceutical Research and Manufacturers of America in connection with its 340B program reform initiative with the National Association of Community Health Centers fleshes out a “coalition” vision of the 10-point reform plan that

…
Read More »

340B Hospitals Say Pharma’s Contract Pharmacy Policies Are Costing Them “Billions of Dollars”

In Pharma Industry, Providers, Research/Reports526 Views Tom Mirga
340B Hospital savings by drug company bar chart
340B Health says, "For just the first five of the 21 drug companies for which there is a full year of data post-restrictions, the 340B savings for hospitals decreased by an estimated $1.1 billion from 2020 to 2021."

Hospitals’ 340B savings for the first five of the 21 companies to impose conditions on 340B pricing when providers use contract pharmacies decreased by an estimated $1.1 billion from 2020 to 2021, hospital group 340B Health said in

…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer